Advertisement

Mitochondrial tRNASer(UCN) 7471delC may be a novel mutation associated with maternally transmitted hypertension

  • Ping Yang
  • Peng Wu
  • Xing Liu
  • Jian Feng
  • Shuzhan Zheng
  • Yan Wang
  • Zhongcai FanEmail author
Original Article
  • 22 Downloads

Abstract

Objective

The objective of the study was to investigate the association between mitochondrial DNA (mtDNA) mutations and essential hypertension (EH).

Methods

One Han Chinese pedigree with maternally inherited EH was recruited in the current study. The matrilineal relatives from this family underwent clinical, genetic, and molecular analysis. Moreover, the mtDNA gene mutations were screened by PCR and direct Sanger sequence. Evolutionary conservation was performed and the secondary structure of mt-tRNASer(UCN) with and without the 7471delC was evaluated by the RNA Fold Webserver program. Moreover, the pathogenicity scoring system was used to assess the 7471delC.

Results

This Chinese pedigree exhibited a relative high penetrance and expressivity of EH. Of 13 matrilineal relatives, 5 of them suffered from high blood pressure (BP). Genetic analysis of the complete mtDNA genes showed the presence of a novel tRNASer(UCN) 7471delC, together with a set of polymorphisms belonging to the human mitochondrial haplogroup G2a1. In fact, the 7471delC occurred within the T-stem and extra arm of tRNASer(UCN), which was very conserved from bacteria to human mitochondria. Interestingly, the 7472insC which was located at the same position had been regarded as a pathogenic mutation associated with non-syndromic hearing loss. In addition, bioinformatics analysis revealed that the 7471delC affected the secondary structure of tRNASer(UCN). The pathogenicity scoring system showed that the 7471delC may be “possibly pathogenic” associated with EH.

Conclusion

We believed that the 7471delC may impair the mitochondrial functional and played an active role in the pathogenesis of EH in this pedigree. The 7471delC may be a novel risk factor for maternally transmitted EH.

Keywords

EH Mitochondrial dysfunction Mt-tRNASer(UCN) 7471delC Novel 

Notes

Funding information

This work is supported by the Grant from Key Laboratory of Medical Electrophysiology of the Ministry of Education (No. KeyME-2017-07).

Compliance with ethical standards

All procedures performed in this study were in accordance with the ethical standards of the institutional and/ or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Competing interests

The authors declare that they have no conflict of interest.

References

  1. 1.
    He J, Whelton PK (1997) Epidemiology and prevention of hypertension. Med Clin North Am 81:1077–1097CrossRefGoogle Scholar
  2. 2.
    Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der Harst P, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, Wain LV, Elliott KS, Teumer A, Luan J, Lucas G, Kuusisto J, Burton PR, Hadley D, McArdle W, Wellcome Trust Case Control Consortium, Brown M, Dominiczak A, Newhouse SJ, Samani NJ, Webster J, Zeggini E, Beckmann JS, Bergmann S, Lim N, Song K, Vollenweider P, Waeber G, Waterworth DM, Yuan X, Groop L, Orho-Melander M, Allione A, di Gregorio A, Guarrera S, Panico S, Ricceri F, Romanazzi V, Sacerdote C, Vineis P, Barroso I, Sandhu MS, Luben RN, Crawford GJ, Jousilahti P, Perola M, Boehnke M, Bonnycastle LL, Collins FS, Jackson AU, Mohlke KL, Stringham HM, Valle TT, Willer CJ, Bergman RN, Morken MA, Döring A, Gieger C, Illig T, Meitinger T, Org E, Pfeufer A, Wichmann HE, Kathiresan S, Marrugat J, O'Donnell CJ, Schwartz SM, Siscovick DS, Subirana I, Freimer NB, Hartikainen AL, McCarthy M, O'Reilly PF, Peltonen L, Pouta A, de Jong PE, Snieder H, van Gilst W, Clarke R, Goel A, Hamsten A, Peden JF, Seedorf U, Syvänen AC, Tognoni G, Lakatta EG, Sanna S, Scheet P, Schlessinger D, Scuteri A, Dörr M, Ernst F, Felix SB, Homuth G, Lorbeer R, Reffelmann T, Rettig R, Völker U, Galan P, Gut IG, Hercberg S, Lathrop GM, Zelenika D, Deloukas P, Soranzo N, Williams FM, Zhai G, Salomaa V, Laakso M, Elosua R, Forouhi NG, Völzke H, Uiterwaal CS, van der Schouw Y, Numans ME, Matullo G, Navis G, Berglund G, Bingham SA, Kooner JS, Connell JM, Bandinelli S, Ferrucci L, Watkins H, Spector TD, Tuomilehto J, Altshuler D, Strachan DP, Laan M, Meneton P, Wareham NJ, Uda M, Jarvelin MR, Mooser V, Melander O, Loos RJ, Elliott P, Abecasis GR, Caulfield M, Munroe PB (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41:666–676CrossRefGoogle Scholar
  3. 3.
    Snieder H, Harshfield GA, Treiber FA (2003) Heritability of blood pressure and hemodynamics in African- and European-American youth. Hypertension 41:1196–1201CrossRefGoogle Scholar
  4. 4.
    Guo H, Zhuang XY, Zhang AM, Zhang W, Yuan Y, Guo L, Yu D, Liu J, Yang DK, Yao YG (2012) Presence of mutation m.14484T>C in a Chinese family with maternally inherited essential hypertension but no expression of LHON. Biochim Biophys Acta 1822:1535–1543CrossRefGoogle Scholar
  5. 5.
    Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP (2004) A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306:1190–1194CrossRefGoogle Scholar
  6. 6.
    Dromparis P, Michelakis ED (2013) Mitochondria in vascular health and disease. Annu Rev Physiol 75(9):5–126Google Scholar
  7. 7.
    Andrews RM, Kubacka I, Chinnery PF et al (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147CrossRefGoogle Scholar
  8. 8.
    Wallace DC (2018) Mitochondrial genetic medicine. Nat Genet 50:1642–1649CrossRefGoogle Scholar
  9. 9.
    Qin Y, Xue L, Jiang P et al (2014) Mitochondrial tRNA variants in Chinese subjects with coronary heart disease. J Am Heart Assoc 3:e000437CrossRefGoogle Scholar
  10. 10.
    Wang S, Li R, Fettermann A, Li Z, Qian Y, Liu Y, Wang X, Zhou A, Mo JQ, Yang L, Jiang P, Taschner A, Rossmanith W, Guan MX (2011) Maternally inherited essential hypertension is associated with the novel 4263A>G mutation in the mitochondrial tRNAIle gene in a large Han Chinese family. Circ Res 108:862–870CrossRefGoogle Scholar
  11. 11.
    Liu Y, Li R, Li Z, Wang XJ, Yang L, Wang S, Guan MX (2009) The mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally hypertension in a Chinese pedigree. Hypertension 53:1083–1090CrossRefGoogle Scholar
  12. 12.
    Xu Y, Chen X, Huang H et al (2017) The mitochondrial tRNAAla T5655C mutation may modulate the phenotypic expression of tRNAMet and tRNAGln A4401G mutation in a Han Chinese family with essential hypertension. Int Heart J 58:95–99CrossRefGoogle Scholar
  13. 13.
    The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (1997) Arch Intern Med 157: 2413–2446Google Scholar
  14. 14.
    Lin L, Cui P, Qiu Z, Wang M, Yu Y, Wang J, Sun Q, Zhao H (2019) The mitochondrial tRNAAla 5587T>C and tRNALeu(CUN) 12280A>G mutations may be associated with hypertension in a Chinese family. Exp Ther Med 17:1855–1862PubMedGoogle Scholar
  15. 15.
    Wang HW, Jia X, Ji Y, Kong QP, Zhang Q, Yao YG, Zhang YP (2008) Strikingly different penetrance of LHON in two Chinese families with primary mutation G11778A is independent of mtDNA haplogroup background and secondary mutation G13708A. Mutat Res 643:48–53CrossRefGoogle Scholar
  16. 16.
    Herrnstadt C, Elson JL, Fahy E et al (2002) Reduced median-network analysis of complete mitochondrial DNA coding region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 70:1152–1171CrossRefGoogle Scholar
  17. 17.
    Ding Y, Teng YS, Zhuo GC, Xia BH, Leng JH (2019) The mitochondrial tRNAHis G12192A mutation may modulate the clinical expression of deafness-associated tRNAThr G15927A mutation in a Chinese pedigree. Curr Mol Med 19:136–146CrossRefGoogle Scholar
  18. 18.
    Wang L, Dong Z, Lin W, Gao R, Chen C, Xu J (2017) Molecular characterization of a pedigree carrying the hypertension-associated mitochondrial tRNAGln T4363C mutation. Mol Med Rep 16:6029–6033CrossRefGoogle Scholar
  19. 19.
    Yarham JW, Al-Dosary M, Blakely EL et al (2011) A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations. Hum Mutat 32:1319–1325CrossRefGoogle Scholar
  20. 20.
    Bibb MJ, Van Etten RA, Wright CT et al (1981) Sequence and gene organization of mouse mitochondrial DNA. Cell 26:167–180CrossRefGoogle Scholar
  21. 21.
    Gadaleta G, Pepe G, De Candia G et al (1989) The complete nucleotide sequence of the Rattus norvegicus mitochondrial genome: cryptic signals revealed by comparative analysis between vertebrates. J Mol Evol 28:497–516CrossRefGoogle Scholar
  22. 22.
    Roe BA, Ma DP, Wilson RK, Wong JF (1985) The complete nucleotide sequence of the Xenopus laevis mitochondrial genome. J Biol Chem 260:9759–9774PubMedGoogle Scholar
  23. 23.
    Tiranti V, Chariot P, Carella F, Toscano A, Soliveri P, Girlanda P, Carrara F, Fratta GM, Reid FM, Mariotti C, Zeviani M (1995) Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet 4:1421–1427CrossRefGoogle Scholar
  24. 24.
    Verhoeven K, Ensink RJ, Tiranti V et al (1999) Hearing impairment and neurological dysfunction associated with a mutation in the mitochondrial tRNASer(UCN) gene. Eur J Hum Genet 7:45–51CrossRefGoogle Scholar
  25. 25.
    Toompuu M, Levinger LL, Nadal A et al (2004) The 7472insC mtDNA mutation impairs 5′ and 3′ processing of tRNA(Ser(UCN)). Biochem Biophys Res Commun 322:803–813CrossRefGoogle Scholar
  26. 26.
    Toompuu M, Yasukawa T, Suzuki T, Hakkinen T, Spelbrink JN, Watanabe K, Jacobs HT (2002) The 7472insC mitochondrial DNA mutation impairs the synthesis and extent of aminoacylation of tRNASer(UCN) but not its structure or rate of turnover. J Biol Chem 277:22240–22250CrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2019

Authors and Affiliations

  • Ping Yang
    • 1
  • Peng Wu
    • 2
  • Xing Liu
    • 1
  • Jian Feng
    • 1
  • Shuzhan Zheng
    • 1
  • Yan Wang
    • 1
  • Zhongcai Fan
    • 1
    • 3
    Email author
  1. 1.Department of VasculocardiologyThe Affiliated Hospital of Southwest Medical UniversityLuzhou CityChina
  2. 2.Cardiovascular Medicine DepartmentYa’an People’s HospitalYa’an CityPeople’s Republic of China
  3. 3.The Key laboratory of Medical ElectrophysiologyMinistry of EducationLuzhou CityPeople’s Republic of China

Personalised recommendations